- Home
- BMY vs BN Comparison
BMY vs BN Comparison
Compare BMY & BN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- BN
- Stock Information
- Founded
- BMY 1887
- BN 1997
- Country
- BMY United States
- BN Canada
- Employees
- BMY N/A
- BN N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- BN Other Consumer Services
- Sector
- BMY Health Care
- BN Consumer Discretionary
- Exchange
- BMY Nasdaq
- BN Nasdaq
- Market Cap
- BMY 94.0B
- BN 103.7B
- IPO Year
- BMY N/A
- BN N/A
- Fundamental
- Price
- BMY $45.09
- BN $68.01
- Analyst Decision
- BMY Hold
- BN Strong Buy
- Analyst Count
- BMY 15
- BN 8
- Target Price
- BMY $57.64
- BN $73.63
- AVG Volume (30 Days)
- BMY 18.1M
- BN 2.6M
- Earning Date
- BMY 10-30-2025
- BN 11-13-2025
- Dividend Yield
- BMY 5.57%
- BN 0.51%
- EPS Growth
- BMY N/A
- BN N/A
- EPS
- BMY 2.49
- BN 0.43
- Revenue
- BMY $47,704,000,000.00
- BN $78,280,000,000.00
- Revenue This Year
- BMY N/A
- BN N/A
- Revenue Next Year
- BMY N/A
- BN $43.01
- P/E Ratio
- BMY $17.92
- BN $153.51
- Revenue Growth
- BMY 2.57
- BN N/A
- 52 Week Low
- BMY $42.96
- BN $43.61
- 52 Week High
- BMY $63.33
- BN $74.20
- Technical
- Relative Strength Index (RSI)
- BMY 45.11
- BN 52.13
- Support Level
- BMY $44.25
- BN $67.11
- Resistance Level
- BMY $48.58
- BN $69.36
- Average True Range (ATR)
- BMY 1.11
- BN 1.41
- MACD
- BMY 0.03
- BN -0.29
- Stochastic Oscillator
- BMY 31.54
- BN 19.04
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BN Brookfield Corporation Limited Voting Shares
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has seven operating segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity, Real Estate and Corporate Activities. It invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. The company generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, Colombia, Germany, Other Europe, Other Asia, and other countries.